Dr. Reddy's Laboratories Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Nov 5, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
DRL filed a 6-K, confirming 20-F annual report submission. Standard procedure.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on November 5, 2024, to report information as a foreign private issuer. The filing indicates the company is submitting its annual reports under Form 20-F. The company's principal executive office is located in Hyderabad, Telangana, India.
Why It Matters
This filing is a routine disclosure for foreign private issuers, providing updates and confirming adherence to reporting requirements with the SEC.
Risk Assessment
Risk Level: low — This is a standard procedural filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 20241105 (date) — Filing Date
- Hyderabad, Telangana, India (location) — Principal Executive Office Location
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information to the SEC.
Which annual report form does Dr. Reddy's Laboratories indicate it files?
Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
Where is the principal executive office of Dr. Reddy's Laboratories located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the filing date of this Form 6-K?
The filing date, as indicated by the accession number and submission details, is November 5, 2024.
Does this filing indicate submission in paper format under Regulation S-T?
No, the filing explicitly states 'No x' for submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) and Rule 101(b)(7).
Filing Stats: 649 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2024-11-05 13:40:56
Filing Documents
- drr0689_6k.htm (6-K) — 18KB
- drr0689_ex99-1.htm (EX-99.1) — 282KB
- drr0689_ex99-2.htm (EX-99.2) — 179KB
- drr0689_ex99-3.htm (EX-99.3) — 292KB
- drr0689_ex99-4.htm (EX-99.4) — 184KB
- drr0689_ex99-1img01.jpg (GRAPHIC) — 9KB
- drr0689_ex99-1img02.jpg (GRAPHIC) — 22KB
- drr0689_ex99-1img03.jpg (GRAPHIC) — 9KB
- drr0689_ex99-1img04.jpg (GRAPHIC) — 5KB
- drr0689_ex99-1img05.jpg (GRAPHIC) — 4KB
- drr0689_ex99-2img01.jpg (GRAPHIC) — 3KB
- drr0689_ex99-2img02.jpg (GRAPHIC) — 2KB
- drr0689_ex99-2img03.jpg (GRAPHIC) — 10KB
- drr0689_ex99-2img04.jpg (GRAPHIC) — 5KB
- drr0689_ex99-3img01.jpg (GRAPHIC) — 9KB
- drr0689_ex99-3img02.jpg (GRAPHIC) — 4KB
- drr0689_ex99-3img03.jpg (GRAPHIC) — 6KB
- drr0689_ex99-3img04.jpg (GRAPHIC) — 3KB
- drr0689_ex99-3img05.jpg (GRAPHIC) — 3KB
- drr0689_ex99-3img06.jpg (GRAPHIC) — 7KB
- drr0689_ex99-3img07.jpg (GRAPHIC) — 9KB
- drr0689_ex99-4img01.jpg (GRAPHIC) — 9KB
- drr0689_ex99-4img02.jpg (GRAPHIC) — 4KB
- drr0689_ex99-4img03.jpg (GRAPHIC) — 3KB
- drr0689_ex99-4img04.jpg (GRAPHIC) — 9KB
- drr0689_ex99-4img05.jpg (GRAPHIC) — 7KB
- drr0689_ex99-4img06.jpg (GRAPHIC) — 3KB
- 0001575872-24-001123.txt ( ) — 1159KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: November 5, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary & Compliance Officer 3